Glipijub, Teneligliptin

Glipijub is used for the treatment of type-2 diabetes mellitus.

Glipijub is known as a Dipeptidyl peptidase-4 (DPP-4) inhibitor, it helps increase the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. Glipijub has down positive results in glycemic control with minimal risk of side effects such as hypoglycemia and weight gain.

Patients who take Glipijub may suffer from such side effects;

Headache,
Hypoglycaemia(minimal),
Upper respiratory tract infection,
Nasopharyngitis,
Constipation